These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 39123167)

  • 1. The role of circular RNAs (circRNAs) as a prognostic factor in lung cancer: a meta-analysis.
    Ahsan S; Win TT; Aye SN; Than NN
    BMC Cancer; 2024 Aug; 24(1):988. PubMed ID: 39123167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRNAs as promising biomarker in diagnostic and prognostic of lung cancer: An updated meta-analysis.
    Yang X; Tian W; Wang S; Ji X; Zhou B
    Genomics; 2021 Jan; 113(1 Pt 1):387-397. PubMed ID: 33326833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic values of circular RNAs for lung cancer: a meta-analysis.
    Yang Q; Chen L; Yang L; Huang Y
    Postgrad Med J; 2021 May; 97(1147):286-293. PubMed ID: 32518074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and diagnostic significance of circRNAs expression in lung cancer.
    Huang X; Zhang W; Shao Z
    J Cell Physiol; 2019 Aug; 234(10):18459-18465. PubMed ID: 30895620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
    Zhang M; Wen F; Zhao K
    J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma.
    Rashedi S; Mardani M; Rafati A; Khavandi MM; Mohammadi F; Javanshir S; Sarallah R; Dolatshahi M; Sabahi M; Azadnajafabad S; Tavolinejad H; Rezaei N
    J Clin Lab Anal; 2022 Oct; 36(10):e24670. PubMed ID: 35989533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of circular RNAs in the diagnosis, prognosis and clinicopathological features of thyroid cancer: A systematic review and meta-analysis.
    Zhu C; Feng Z; Hong F; Sun H; Wang Z; Zhao Z; Zhang F
    Pathol Res Pract; 2022 Aug; 236():153871. PubMed ID: 35797852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
    Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
    Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Zhan B; Lu D; Luo P; Wang B
    Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
    Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Role of Circular RNAs Expression in Bladder Carcinoma: A Meta-Analysis.
    Wang S; Fu S; Chen Q; Liu Y; Li Z; Sun T
    Genet Test Mol Biomarkers; 2020 Nov; 24(11):692-700. PubMed ID: 33030352
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated Expression Levels of Circular RNAs Serve as Prognostic and Clinicopathological Markers in Gastric Cancer: a Meta-Analysis.
    Zhao G; Wu Y; Wu L; Huang J; Gan Y; Li H
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and clinicopathological significance of tertiary lymphoid structure in non-small cell lung cancer: a systematic review and meta-analysis.
    Ma L; Li R; Liu X; Yu W; Tang Z; Shen Y; Tian H
    BMC Cancer; 2024 Jul; 24(1):815. PubMed ID: 38977962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer.
    Li C; Zhang L; Meng G; Wang Q; Lv X; Zhang J; Li J
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2875-2889. PubMed ID: 31630262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of dysregulated circRNAs in patients with non-small cell lung cancer: a meta-analysis.
    Bao Q; Li F; Zheng H; Chen S; Song X
    J Thorac Dis; 2020 Mar; 12(3):823-829. PubMed ID: 32274149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and diagnostic significance of circRNAs expression in hepatocellular carcinoma patients: A meta-analysis.
    Huang X; Zhang W; Shao Z
    Cancer Med; 2019 Mar; 8(3):1148-1156. PubMed ID: 30693679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review and Meta-Analysis of the Utility of Circular RNAs as Biomarkers of Hepatocellular Carcinoma.
    Hao Q; Han Y; Xia W; Wang Q; Qian H
    Can J Gastroenterol Hepatol; 2019; 2019():1684039. PubMed ID: 31187026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis.
    Zhong J; Zhang G; Yao W
    J Orthop Surg Res; 2021 Oct; 16(1):578. PubMed ID: 34620208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
    Zhao S; Qiu Z; He J; Li L; Li W
    Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.